Rafael Holdings Inc (RFL) Directors and Executive Officers

Officers & Directors

William Conkling
President and Chief Executive Officer (Principal Executive Officer)

Howard S. Jonas
Director, Chairman of the Board and Executive Chairman

Dr. Mark Stein
Director

David Polinsky
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Stephen Greenberg
Director

Dr. Michael J. Weiss
Director

Susan Y. Bernstein
Director

CohnRenzick LLP
; ,

Rafael Holdings Inc currently has 23 employees.

News about Rafael Holdings Inc Key Personnel

Rafael Holdings Realigns Focus on Trappsol Cyclo Amid Leadership Changes and Significant Clinical Trial Milestone

In an era where the advancement of medical treatments for rare diseases is of paramount importance, Rafael Holdings has reaffirmed its commitment to the development of Trappsol Cyclo, a promising investigational drug for Niemann-Pick Disease Type C1 (NPC1). This milestone announcement comes alongside notable leadership changes as chief executive officer Bill Conkling prepares to step down from his role. Niemann-Pick Disease Type C1 is a rare and genetically inherited disorder characterized by lysosomal dysfunction, which profoundly impacts the body s ability to metabolize lipids. This condition generally leads to severe neurological impairment and systemic symptoms, significantly affecting the lives of the i...